Results 121 to 130 of about 132,344 (172)

[Spousal correlations of blood lipid based on a family design]. [PDF]

Beijing Da Xue Xue Bao Yi Xue Ban
Li Y, Guo H, Peng H, Hou T, Zhang H, Tan Y, Zheng Y, Wang M, Wu Y, Qin X, Li J, Ye Y, Wu T, Chen D, Hu Y, Li L.   +15 more
europepmc   +1 more source

[Electroacupuncture at Zusanli improves blood lipid disorders in hyperlipidemic mice by improving gut microbiota structure]. [PDF]

Nan Fang Yi Ke Da Xue Xue Bao
Deng C, Wang X, Gan L, Wang D, Zheng X, Tang C.   +5 more
europepmc   +1 more source

[Association of Serum Myeloperoxidase and Lipid Levels With Coronary Artery Lesion Severity and Major Adverse Cardiovascular Events in Patients With Acute Coronary Syndrome]. [PDF]

Sichuan Da Xue Xue Bao Yi Xue Ban
Li Y, Li X.
europepmc   +1 more source

Transtext(e)s Transcultures è,è - Journal of Global Cultural Studies

Cléo Radar, 2009
openaire   +1 more source

鉄欠乏性貧血者(若年女性)の血清および摂取脂肪酸組成の検討

, 1998
P(論文)1.
海老沼, 春世, 里和, スミヱ
core   +1 more source

Hyper Lpidemia : Diet Therapy and Pharmaco Therapy

, 2003
高脂血症の治療は大きく食事療法と薬物療法からなる.食事療法はカロリーや脂肪の制限,脂肪酸組成などが重要である.薬物療法の有効性と安全性に関するエビデンスが蓄積されて来た.主要な治療薬にはスタテン,レジン,フイブラート,ニコチン酸,プロブコール,EPAなどがある.このうち,スタチンに関しては,1次予防と2次予防試験の双方で心血管イベントのみならず,死亡率抑制効果が証明されている.副作用や薬物相互作用などに配慮して適正な薬物療法を行いたい.特集Special Editionjournal ...
石橋, 俊, イシバシ, シュン, Ishibashi, Shun   +2 more
core   +1 more source

[A case of neonatal fatty acid oxidation disorder]. [PDF]

Zhongguo Dang Dai Er Ke Za Zhi
Deng LL, Zou HM, Cheng TT, Yuan Y, Zhang HY.   +4 more
europepmc   +1 more source

[Interpretation of the Expert Consensus Statement on the Role of Vitamin D in Metabolic Health]. [PDF]

Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi
Zhao Z, Zeng Y.
europepmc   +1 more source

[A case of acetaminophen-induced cholestatic liver injury accompanying severe hypercholesterolemia in children]. [PDF]

Zhonghua Gan Zang Bing Za Zhi
Chen L, Gao XY, Liu XY, Shao YL.
europepmc   +1 more source

[Research progress in mechanisms of dietary resistant starch for regulating glucose and lipid metabolism]. [PDF]

Nan Fang Yi Ke Da Xue Xue Bao
Liu K, Li X, Zhang Y, Sun J, Liao W.
europepmc   +1 more source